Integrin-linked Kinase and Renal Interstitial Fibrosis

整合素连接激酶与肾间质纤维化

基本信息

  • 批准号:
    7431698
  • 负责人:
  • 金额:
    $ 24.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-06-01 至 2010-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tubulointerstitial fibrosis is considered as a final common outcome of a wide range of chronic kidney diseases (CKD), regardless of the initial causes. The pathogenesis of interstitial fibrosis is a remarkably monotonous process characterized by de novo activation of the matrix-producing myofibroblasts. Evidence indicates that a large proportion of interstitial fibroblasts are actually originated from tubular epithelial cells via epithelial to mesenchymal transition (EMT). However, the mechanism underlying tubular EMT remains elusive. Studies from the applicant's laboratory demonstrate that integrin-linked kinase (ILK), an intracellular serine/threonine protein kinase that interacts with the cytoplasmic domains of (-integrins, plays an imperative role in mediating tubular EMT and renal interstitial fibrogenesis. The central hypotheses of this application are that: 1) ILK is a central element of a multi-component cellular machinery, and the function of ILK depends on its interactions with key partners; 2) ILK plays an imperative role in the maintenance of tubular cell phenotypes and matrix homeostasis in vivo; and 3) ILK is a prime molecular target for designing an effective therapy for chronic renal fibrosis. These hypotheses will be tested in the following four specific Aims. Aim 1 is to investigate the ILK interactions with its partners and to elucidate their functional significance in mediating tubular EMT. Aim 2 will delineate the role of PINCH, a key partner of ILK, in mediating tubular EMT and renal fibrosis. Aim 3 is designed to investigate the physiologic and pathologic role of ILK in renal tubules in vivo by conditional knockout approach. Aim 4 will evaluate the therapeutic efficacy of ILK inhibitor for renal interstitial fibrosis. These studies will not only provide mechanistic insights into understanding the regulation of tubular EMT in the setting of CKD, but also offer unique opportunities for designing rational strategies for the treatment of chronic renal fibrosis.
描述(由申请人提供):管间质纤维化被认为是多种慢性肾脏疾病(CKD)的最终常见结果,无论其初始原因如何。间质纤维化的发病机制是一个非常单调的过程,其特征是产生基质的肌成纤维细胞的重新激活。有证据表明,很大一部分间质成纤维细胞实际上是由小管上皮细胞通过上皮向间充质转化(EMT)产生的。然而,管状EMT的机制仍然难以捉摸。申请人实验室的研究表明,整合素连接激酶(ILK)是一种细胞内丝氨酸/苏氨酸蛋白激酶,与(-整合素)的细胞质结构域相互作用,在介导小管EMT和肾间质纤维化中起着重要作用。该应用的中心假设是:1)ILK是多组分细胞机制的中心元素,ILK的功能取决于其与关键伙伴的相互作用;2) ILK在维持体内小管细胞表型和基质稳态中起重要作用;3) ILK是设计有效治疗慢性肾纤维化的主要分子靶点。这些假设将在以下四个具体目标中进行测试。目的1是研究ILK与其伙伴的相互作用,并阐明它们在介导管状EMT中的功能意义。目的2将描述PINCH在介导小管EMT和肾纤维化中的作用,PINCH是ILK的一个关键伙伴。目的3旨在通过条件敲除方法研究ILK在体内肾小管中的生理和病理作用。目的4评价ILK抑制剂治疗肾间质纤维化的疗效。这些研究不仅为理解CKD背景下肾小管EMT的调控提供了机制见解,而且还为设计慢性肾纤维化治疗的合理策略提供了独特的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOUHUA LIU其他文献

YOUHUA LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOUHUA LIU', 18)}}的其他基金

Beta-catenin Signaling and Podocyte Dysfunction
β-连环蛋白信号传导和足细胞功能障碍
  • 批准号:
    8467710
  • 财政年份:
    2012
  • 资助金额:
    $ 24.58万
  • 项目类别:
Beta-catenin Signaling and Podocyte Dysfunction
β-连环蛋白信号传导和足细胞功能障碍
  • 批准号:
    8236328
  • 财政年份:
    2012
  • 资助金额:
    $ 24.58万
  • 项目类别:
Beta-catenin Signaling and Podocyte Dysfunction
β-连环蛋白信号传导和足细胞功能障碍
  • 批准号:
    8665413
  • 财政年份:
    2012
  • 资助金额:
    $ 24.58万
  • 项目类别:
Beta-catenin Signaling and Podocyte Dysfunction
β-连环蛋白信号传导和足细胞功能障碍
  • 批准号:
    8846592
  • 财政年份:
    2012
  • 资助金额:
    $ 24.58万
  • 项目类别:
Integrin-linked Kinase and Renal Interstitial Fibrosis
整合素连接激酶与肾间质纤维化
  • 批准号:
    6912066
  • 财政年份:
    2005
  • 资助金额:
    $ 24.58万
  • 项目类别:
Integrin-linked Kinase and Renal Interstitial Fibrosis
整合素连接激酶与肾间质纤维化
  • 批准号:
    7241478
  • 财政年份:
    2005
  • 资助金额:
    $ 24.58万
  • 项目类别:
Integrin-linked Kinase and Renal Interstitial Fibrosis
整合素连接激酶与肾间质纤维化
  • 批准号:
    7068667
  • 财政年份:
    2005
  • 资助金额:
    $ 24.58万
  • 项目类别:
Renal Myfibroblast: Origins and Activation
肾肌成纤维细胞:起源和激活
  • 批准号:
    8695332
  • 财政年份:
    2003
  • 资助金额:
    $ 24.58万
  • 项目类别:
Renal myofibroblast: Origin, Activation and Fate
肾肌成纤维细胞:起源、激活和命运
  • 批准号:
    7885612
  • 财政年份:
    2003
  • 资助金额:
    $ 24.58万
  • 项目类别:
Renal myofibroblast: Origin, Activation and Fate
肾肌成纤维细胞:起源、激活和命运
  • 批准号:
    7524141
  • 财政年份:
    2003
  • 资助金额:
    $ 24.58万
  • 项目类别:

相似海外基金

心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
  • 批准号:
    24K11201
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
  • 批准号:
    24K11281
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
  • 批准号:
    2338890
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334777
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334775
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
  • 批准号:
    EP/Z001145/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334776
  • 财政年份:
    2024
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
  • 批准号:
    2320040
  • 财政年份:
    2023
  • 资助金额:
    $ 24.58万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了